Dramatic response to single-agent rituximab in a patient with intravascular lymphoma.
Vrindavanam
Nandagopal
N
Hamadani
Mehdi
M
Steele
Barbara
B
Awan
Farrukh
F
Suster
Saul
S
Benson
Don M
DM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001808:Blood Vessels / Q000187:drug effects / Q000473:pathology; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab